← Open Payments lookup

BENJAMIN HAYDEN: Open Payments

NPI 1841236437 · MANGHAM, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$989 in 12 payments from 11 companies in 2025. Trend: 2023 $1,402 · 2024 $460 · 2025 $989

Food & beverage: $989
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.1$129
Insulet Corporation1$124
AstraZeneca Pharmaceuticals LP1$122
Astellas Pharma US Inc1$120
Novo Nordisk Inc1$103
Boston Scientific Corporation1$92
Boehringer Ingelheim Pharmaceuticals, Inc.1$83
Stryker Corporation1$82
Amgen Inc.1$80
Vanda Pharmaceuticals Inc.2$36

Products named: Omnipod, BREZTRI, Veozah, Ozempic, Intracept, JARDIANCE, OTEZLA, FANAPT.

Industry payments across LA — which companies pay providers there.